$HEB News Wednesday's biggest gaining and declining

New Post Public Reply Private Reply Replies (0) Message Board

Jul 13, 2014 at 1:02 PM

$HEB News

Wednesday's biggest gaining and declining stocks 6:03 p.m. Dec. 2, 2009 - MarketWatch
Dyax, Santarus, CytRx soar; Hemispherx craters 12:38 p.m. Dec. 2, 2009 - Val Brickates Kennedy
Stocks in focus for Wednesday 7:47 p.m. Dec. 1, 2009 - MarketWatch
Ford tips higher, Santarus surges in late session 7:37 p.m. Dec. 1, 2009 - Laura Mandaro
Hemispherx Biopharma shares sink 44% after hours 6:29 p.m. Dec. 1, 2009 - Laura Mandaro
Oops: I have to eat crow over these stupid picks 9:55 a.m. June 19, 2009 - Chuck Jaffe
Vaccine makers get boost from flu scare 1:20 p.m. May 21, 2009 - Val Brickates Kennedy
Hemispherx leads drug stocks lower 1:29 p.m. May 19, 2009 - Val Brickates Kennedy
Dr. Reddy's, Hemispherx lead drug stocks 1:24 p.m. May 18, 2009 - Val Brickates Kennedy
Pigs will get slaughtered on swine-flu stocks 6:27 p.m. April 30, 2009 - Chuck Jaffe
Shares of antiviral drugmakers rocket on flu news 1:54 p.m. April 27, 2009 - Val Brickates Kennedy
Niche antiviral drugmakers rocket on flu news 10:08 a.m. April 27, 2009 - Val Brickates Kennedy
Hemispherx started at mkt outperform: Boenning & Scattergood 3:47 p.m. Dec. 4, 2006 - Tomi Kilgore
Tuesday's biggest stock gainers and decliners 6:21 p.m. Aug. 29, 2006 - Michael Baron
Short sellers dwindle as multiple forces aim to thwart strategy 11:51 a.m. June 14, 2006 - Alistair Barr
Highlights of rising and falling U.S. stocks 4:58 p.m. May 24, 2006 - MarketWatch
Bird-flu concerns knock airlines, Asian currencies 4:52 p.m. May 24, 2006 - Steve Goldstein
Drug stocks mixed, bird-flu drugmakers rally 4:51 p.m. May 24, 2006 - Val Brickates Kennedy
Hemisherx BioPharma up 10% at $2.95 9:39 a.m. May 24, 2006 - Tomi Kilgore
Drug stocks end mixed; Serono dives on sale plan 4:40 p.m. April 10, 2006 - Val Brickates Kennedy

10-K: HEMISPHERX BIOPHARMA INC 4:06 p.m. March 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-Q: HEMISPHERX BIOPHARMA INC 5:06 p.m. Nov. 8, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-Q: HEMISPHERX BIOPHARMA INC 4:15 p.m. Aug. 9, 2013 - Edgar Online - (EDG = 10Q, 10K)
Biotechs Ramping Up On China's Avian Flu Outbreak 2:42 a.m. April 8, 2013 - Seeking Alpha
Biotech Movers: A Doubler for Opexa 3:30 a.m. Feb. 11, 2013 - InvestorPlace.com
2 Biotech Stocks That Could Be Prime Candidates For The Short Seller 12:18 p.m. Dec. 21, 2012 - Seeking Alpha
Panel Rejects Drug for Chronic Fatigue Syndrome 7:52 p.m. Dec. 20, 2012 - The Wall Street Journal Interactive Edition
Amgen Licenses ImmunoGen Tech, Hemispherx Drug Questioned by FDA: Healthcare Business Recap 4:25 p.m. Dec. 19, 2012 - Wall St. Cheat Sheet
Stock Watch Wednesday, 19 December 10:24 a.m. Dec. 19, 2012 - Seeking Alpha
Hemispherx Faces FDA Day 7:51 a.m. Dec. 19, 2012 - Seeking Alpha
FDA Questions Hemispherx's Fatigue Drug 6:12 p.m. Dec. 18, 2012 - The Wall Street Journal Interactive Edition
Strong Small Cap Biopharma Catalyst Trades And Investments For Consideration 8:55 a.m. Dec. 18, 2012 - Seeking Alpha
Hemispherx's Ampligen Is Unlikely To Receive FDA Approval 6:46 a.m. Dec. 18, 2012 - Seeking Alpha
Potential Drug for Fatigue to Get New Review 11:21 p.m. Dec. 16, 2012 - The Wall Street Journal Interactive Edition
Ampligen: The Political Calculus Has Changed 6:37 a.m. Dec. 12, 2012 - Seeking Alpha
Tuesday's Small-Cap Biopharma Catalyst Trade List 9:45 a.m. Dec. 11, 2012 - Seeking Alpha
Hemispherx's Ampligen For The Treatment Of Chronic Fatigue Syndrome: A Regulatory Conundrum 5:52 a.m. Dec. 9, 2012 - Seeking Alpha
Hemispherx Biopharma: A Voice Of Reason Amid The Din 8:34 a.m. Dec. 4, 2012 - Seeking Alpha
3 Stocks With High Alphas: Acadia, Hemispherx, And Vringo 10:50 a.m. Nov. 8, 2012 - Seeking Alpha
Savient Pharmaceuticals May Continue To Run Higher 1:10 p.m. Oct. 9, 2012 - Seeking Alpha

Hemispherx Biopharma and Bioclones Join Forces in Effort to Eradicate HIV/AIDS Virus Based on Recent Clinical Insights of Wistar Institute, University of Pennsylvania 8:31 a.m. July 8, 2014 - GlobeNewswire
Hemispherx Biopharma to Present During the 2014 BIO International Convention June 26 8:30 a.m. June 25, 2014 - GlobeNewswire
Hemispherx Announces New Publication With Potential Insight Into High Mortality Rate in Middle Eastern Respiratory Syndrome (MERS) 8:31 a.m. June 16, 2014 - GlobeNewswire
Hemispherx Announces That the University of Texas Medical Branch Confirms Activity of Alferon(R) N Against MERS (Middle East Respiratory Syndrome) Virus 1:08 p.m. June 3, 2014 - GlobeNewswire
Hemispherx Receives New U.S. Composition of Matter Patent Covering Ampligen(R) Formulations 9:28 a.m. May 27, 2014 - GlobeNewswire
Hemispherx and GP Pharm Agree to Establish a Manufacturing Operation in Argentina to Serve Latin America Markets and Ancillary Markets 8:31 a.m. May 21, 2014 - GlobeNewswire
Hemispherx Biopharma Formally Collaborates With the Swiss Department of Defense, Civil Protection and Sports to Study Alferon(R) Against Tamiflu Resistant Influenza Virus Strains 8:31 a.m. May 14, 2014 - GlobeNewswire
Hemispherx Biopharma Announces Financial Results for the Three Months Ended March 31, 2014 4:16 p.m. May 9, 2014 - GlobeNewswire
Technical Recap on Biotech Equities -- Research on Hemispherx Biopharma, Orexigen Therapeutics, Dynavax Technologies, and Synergy Pharma 2:30 p.m. May 8, 2014 - PR Newswire - PRF
Alferon(R) N Effective Against MERS (Middle East Respiratory Syndrome) Virus In-Vitro 8:32 a.m. May 5, 2014 - GlobeNewswire
Coverage of Biotech Equities -- Research on Arena Pharma, Celgene, PDL BioPharma, and Hemispherx Biopharma 1:20 p.m. April 8, 2014 - PR Newswire - PRF
Hemispherx Biopharma Announces New Publication Enlarges the Understanding of Ampligen(R) Safety Profile Across Diverse Animal Species and Focuses on the Unique TLR-3 Receptor/Ampligen(R) Interaction 8:31 a.m. April 8, 2014 - GlobeNewswire
Hemispherx Biopharma, Inc. Presented Clinical Interpretations on CFS Treatment at the 11th Biennial International Research and Clinical Conference 8:33 a.m. March 24, 2014 - GlobeNewswire
Momentum Indicators for Health Care Equities -- Research on Arena Pharma, Hemispherx Biopharma, PDL BioPharma and Celgene 8:16 a.m. March 20, 2014 - PR Newswire - PRF
Hemispherx Biopharma, Inc. to Present Clinical Interpretations on CFS Treatment at the 11th Biennial International Research and Clinical Conference 8:30 a.m. March 19, 2014 - GlobeNewswire
Hemispherx Biopharma Announces Financial Results for the Year Ended December 31, 2013 8:30 a.m. March 14, 2014 - GlobeNewswire
Hemispherx Biopharma Announces Plans to File for Regulatory Approval of Ampligen(R) to Treat Chronic Fatigue Syndrome (CFS) in Three Additional Latin America Countries 11:01 a.m. March 10, 2014 - GlobeNewswire
Hemispherx Biopharma Wins Federal Lawsuit Regarding Investment Banking Fees 8:30 a.m. March 10, 2014 - GlobeNewswire
Hemispherx Biopharma Publishes Full National Press Club Presentation on Corporate Website 9:30 a.m. Feb. 24, 2014 - GlobeNewswire
Hemispherx Biopharma Summarizes Clinical Results Presented in Washington, DC on January 30, 2014 in Conjunction with the American Society for Microbiology (ASM) Biodefense Conference Aimed at Developing a Universal Influenza Vaccine to Prevent Pandemic Influenza Threat 11:48 p.m. Feb. 4, 2014 - GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fermi's Founder Pushes for Board Overhaul: What's Next?

Fermi's Roller Coaster: A Founder’s Stand Seems like Fermi Inc. is on a wild ride through the business landscape, and it's giving shareholders more whiplash than satisfaction these days. Toby Neugebauer, co-founder of Fermi and the loudest voice in the room, is feeling like his company is facing some serious turbulence and seems determined not to sit idly by as it hits...

Sustainability Investments: $17 Trillion Wager Faces Divergence

Sustainability Investments: A Tale of Contrasts In the world of sustainability, a staggering $17 trillion has been poured into technologies over the past decade. That’s no chump change. But what do we have to show for it? According to Bain & Company’s latest report, this massive financial injection hasn’t exactly hit a home run. Progress, much like the stock market...

DCM Services Teams with AKUVO to Boost Estate Recoveries

Revolutionizing Estate Recovery Practices Here's the scoop: DCM Services (DCMS), that big shot in estate account resolution, is hooking up with AKUVO to shake up how credit unions handle estate recoveries. This alliance is a clear nod to modernizing a process stuck in the past. Let’s face it, handling decedent and probate accounts is no cakewalk, and traditional methods...

Lick the Plate Hits 2,000 Shows with Clown Band

They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...

High-Grade Copper Spurs Optimism for PolarX in Alaska

Copper's New Pulse: PolarX Makes Waves in Alaska Ever hear about striking copper so rich it's practically shimmering? Well, PolarX Limited just might have hit that sweet spot up in the rugged expanses of Alaska. Let me tell you, when you're knee-deep in resources, like what they’re discovering at the Caribou Dome Project, it sure feels like you’ve struck modern-day...

Americas Cardroom's Poker Series Hits $7.2M Haul

Massive Prize Pools Emerge in Just Four Days I found myself eyeballing some jaw-dropping numbers from Americas Cardroom's latest poker series, the Online Super Series XL. It's not every day you see nearly a hundred tournaments rake in over $7.2 million in prize pools in just four days. From September 6th to 9th, a whopping 62,847 entries signed up to make an honest...

NYSE Reflects on 9/11: Honoring Lives and Legacy

A Somber Day at NYSE: Reflecting on 9/11 September 11th grips the heart of NYSE every year, but this year's 25th-anniversary powerfully reverberates through its hallowed halls. The hustle of the trading floor halts for a moment at 9:20 AM ET, paying homage to those lost in the harrowing attacks. I've seen the markets flap in the wind of countless crises, but nothing's...

Streamlined AI Video Analytics for Public Safety Unveiled

AI Without the Headache Alright folks, IREX is shaking things up, and not in the usual iterative, bit-by-bit tech progression way. StreamVLM™ has been rolled out as the world's first vision-language model (VLM) analytics engine tailored for the public safety sector—specifically, for cloud platforms. I’ve been around the block enough times to spot a significant shift...

2026 Buy-Side Index Reveals State Market Variance

Toss out your one-size-fits-all real estate predictions; the Q2 2026 Buy-Side Index just unveiled some real whoppers about the housing market. What we're seeing isn't your typical year-over-year growth across the board. Nope, we're seeing splits as sharp as a knife between states. Some places are shooting up in price, while others seem to be stuck in mud. Price Surges and...

Intus Bio Secures $2.7M for Colorectal Cancer Test

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...